Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:developedBy |
plant-based pharmaceuticals
|
| gptkbp:focusesOn |
rare diseases
gastrointestinal disorders |
| gptkbp:foundedYear |
2001
|
| gptkbp:founder |
Lisa Conte
|
| gptkbp:headquartersLocation |
gptkb:San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Napo Pharmaceuticals
|
| gptkbp:indication |
irritable bowel syndrome
inflammatory bowel disease HIV-related diarrhea |
| gptkbp:notableProduct |
crofelemer
|
| gptkbp:parentCompany |
Jaguar Health
|
| gptkbp:publiclyTraded |
no
|
| gptkbp:website |
https://www.napopharma.com/
|
| gptkbp:bfsParent |
gptkb:Crofelemer
|
| gptkbp:bfsLayer |
8
|